MANE Veradermics, Incorporated Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
00:55
Feb 03
r/pennystocks
Buy Veradermics IPO for breakthrough hair-loss drug
VDPHL01 is an extended-release formulation of minoxidil that eliminates the blood-concentration spike, allowing a much higher dose without heart side effects and driving stronger hair regrowth. The author expects Phase III trial results in the first and second half of this year and potential FDA approval by H2 2027, and plans to buy the IPO and add over two years. The main stated risk is short-term volatility for investors unable to hold through catalysts.
MANE Veradermics, Incorporated Long 1ST — —

About MANE Investor Commentary

Across the available history and selected sources, Buzzberg tracks MANE (Veradermics, Incorporated) across 4 sources: 1 bullish vs 0 bearish calls from 4 authors. Historical directional balance: 12% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 8 total trade ideas tracked. Past 7 days, before deduplication: 2 other directions. Latest voices: u/le_Menace.